Alternatives to Dotmatics

R&D cloud platform for life sciences, enabling scientific innovation and productivity.

IDBS provides a cloud-based platform for scientific data management and collaboration.

AI-powered platform unifying R&D data for accelerated product development.

Labtoto is a platform for managing and automating laboratory workflows and data.

AI operating system for R&D teams in formulation industries.

A global biotechnology company discovering, developing, manufacturing, and delivering innovative human therapeutics.

A global oncology company developing and commercializing innovative cancer treatments.

Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.

Synthace provides a no-code cloud platform for life sciences R&D, enabling scientists to automate experimentation and insight sharing.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

Biotechnology company developing gene therapies and regenerative medicine for heart disease.

AI-powered platform for personalized cell therapy development and manufacturing.

Biopharmaceutical company developing novel therapies for rare and ultra-rare genetic diseases.

A precision biotechnology company developing a blood-based platform for early cancer detection and treatment.

Adimab is a biotechnology company that discovers and develops therapeutic antibodies using its proprietary yeast-based platform.

Gene therapy company developing transformative treatments for severe genetic diseases.

Gene therapy company developing treatments for rare inherited diseases.

Ridge Bio is developing a novel gene therapy platform for treating rare genetic diseases.

Biopharmaceutical company developing antibody-based therapeutics for cancer and autoimmune diseases.

Metly empowers pharma companies to accelerate product launches through intelligent opportunity detection and partner matching.

A clinical-stage biotechnology company developing transformative genome editing medicines for serious diseases.

A clinical-stage genome editing company developing novel therapies using CRISPR/Cas9 technology for severe diseases.

Biostax provides a cloud-based platform for life sciences research, enabling data integration and analysis.

SNIPR Biome is a clinical-stage company developing CRISPR-based therapeutics to precisely target and eliminate specific bacteria in the human microbiome.

Develops advanced gene editing and cell therapy solutions for rare genetic diseases.

AI-powered biotech platform using protein design to discover novel therapeutic molecules for hard-to-treat targets.

Leveraging the adaptive immune system to diagnose and treat disease.

Biotechnology company focused on developing treatments for rare metabolic diseases.

Phenomics-driven AI company translating disease biology into precision medicine discoveries.

Developing novel therapeutics by understanding the complex interplay of biological systems.

AI-powered biotechnology company developing RNA therapeutics for genetic diseases.

Mapping cell-cell communication at scale in human tissue.

Cloud-native platform for scalable and reproducible bioinformatics workflows.

Teknova provides critical reagents for biopharmaceutical product development and production.

ImCheck Therapeutics is a clinical-stage immuno-oncology company developing novel antibody therapies.

Developing novel therapeutics targeting dysfunctional DNA packaging for diseases like cancer.

Vexxel is developing a novel platform for cell-free protein synthesis and engineering.

Biopharmaceutical company focused on developing and commercializing innovative treatments for rare neurological disorders.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Clinical-stage biopharmaceutical company developing gene therapies for rare genetic diseases.

Ophthalmic pharmaceutical company developing novel treatments for ocular diseases.

Clinical-stage biotech company developing AAV gene therapies for rare and retinal diseases.

Biotechnology company developing immuno-neurology therapies for neurodegenerative diseases.

Biotech startup developing laser bioprinting systems for regenerative medicine and biosensor applications.

Clinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases.

Develops and markets bioproduction tools for cell and gene therapy manufacturing and distribution.

Developing novel therapeutics for rare genetic diseases with a focus on protein degradation.

Biotechnology company developing novel immunotherapies for cancer.

Biopharmaceutical company developing transformative therapies for rare metabolic diseases, focusing on hyperinsulinism.

AI-powered platform for drug discovery and development, accelerating research with advanced analytics.

PFx Biotech is developing a novel platform for the discovery and development of protein-based therapeutics.

BioGene Therapeutics is a life sciences company developing novel gene therapy solutions for metabolic disorders like diabetes and obesity.

A global, research-driven biopharmaceutical group focused on reproductive medicine, maternal health, and other specialized therapeutic areas.

Global life sciences company providing diagnostic and biopharma laboratory services.

OMGene is a biotechnology company focused on developing gene therapies for rare genetic diseases.

Atomwise uses AI to accelerate the discovery of novel small molecule therapeutics with its AtomNet platform.

Develops novel protein engineering and directed evolution technologies for therapeutic discovery.

A biotechnology company focused on extending healthy human lifespan by targeting the biological causes of aging.

Clinical research organization providing software and data analytics for drug development.